Schrodinger Revenue 2019-2024 | SDGR
Schrodinger revenue from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Schrodinger Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $217 |
| 2022 | $181 |
| 2021 | $138 |
| 2020 | $108 |
| 2019 | $86 |
| 2018 | $67 |
| Schrodinger Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $35 |
| 2024-06-30 | $47 |
| 2024-03-31 | $37 |
| 2023-12-31 | $74 |
| 2023-09-30 | $43 |
| 2023-06-30 | $35 |
| 2023-03-31 | $65 |
| 2022-12-31 | $57 |
| 2022-09-30 | $37 |
| 2022-06-30 | $38 |
| 2022-03-31 | $49 |
| 2021-12-31 | $46 |
| 2021-09-30 | $30 |
| 2021-06-30 | $30 |
| 2021-03-31 | $32 |
| 2020-12-31 | $33 |
| 2020-09-30 | $26 |
| 2020-06-30 | $23 |
| 2020-03-31 | $26 |
| 2019-12-31 | $26 |
| 2019-09-30 | $20 |
| 2019-06-30 | $19 |
| 2019-03-31 | $21 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.644B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.855B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.039B | 179.00 |
| Inspire Medical Systems (INSP) | United States | $5.776B | 180.15 |
| Enovis (ENOV) | United States | $2.727B | 18.49 |
| IRhythm Technologies (IRTC) | United States | $2.722B | 0.00 |
| Privia Health (PRVA) | United States | $2.578B | 214.80 |
| Omnicell (OMCL) | United States | $2.158B | 70.59 |
| Azenta (AZTA) | United States | $2.106B | 112.71 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.744B | 0.00 |
| Phreesia (PHR) | United States | $1.215B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Talkspace (TALK) | United States | $0.578B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.546B | 94.60 |
| Health Catalyst (HCAT) | United States | $0.537B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 78.04 |
| Pulmonx (LUNG) | United States | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.223B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.109B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.082B | 0.00 |
| 111 (YI) | China | $0.071B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.047B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |